GeorgePKinzfoglIIIMD

PubMed

• The cross-section of routine practice of echocardiographic diastolic evaluation in atrial fibrillation in a community hospital: A quality improvement project.
  Ji Hyun Yang, Sourbha S Dani, Seong Yoon Kim, George Kinzfogl, Eric Davidson> ;Echocardiography. 2022 Dec 1
• Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab.
  Hagström E, Steg PG, Szarek M, Bhatt DL, Bittner VA, Danchin N, Diaz R, Goodman SG, Harrington RA, Jukema JW, Liberopoulos E, Marx N, McGinniss J, Manvelian G, Pordy R...> ;Circulation. 2022-06-30
• Worldwide Disparities in Recovery of Cardiac Testing 1 Year Into COVID-19.
  Einstein AJ, Hirschfeld C, Williams MC, Vitola JV, Better N, Villines TC, Cerci R, Shaw LJ, Choi AD, Dorbala S, Karthikeyan G, Lu B, Sinitsyn V, Ansheles AA, Kudo T, B...> ;Journal of the American College of Cardiology.
• Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol.
  Schwartz GG, Szarek M, Bittner VA, Diaz R, Goodman SG, Jukema JW, Landmesser U, López-Jaramillo P, Manvelian G, Pordy R, Scemama M, Sinnaeve PR, White HD, Gabriel Steg...> ;Journal of the American College of Cardiology.
• International Impact of COVID-19 on the Diagnosis of Heart Disease.
  Einstein AJ, Shaw LJ, Hirschfeld C, Williams MC, Villines TC, Better N, Vitola JV, Cerci R, Dorbala S, Raggi P, Choi AD, Lu B, Sinitsyn V, Sergienko V, Kudo T, Nørgaar...> ;Journal of the American College of Cardiology.
• Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment.
  Schwartz GG, Szarek M, Bittner VA, Bhatt DL, Diaz R, Goodman SG, Jukema JW, Loy M, Manvelian G, Pordy R, White HD, Steg PG, ODYSSEY OUTCOMES Committees and Investigators> ;Diabetes care. 2021-03-15
• Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSS...
  Ray KK, Colhoun HM, Szarek M, Baccara-Dinet M, Bhatt DL, Bittner VA, Budaj AJ, Diaz R, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Loizeau V, Lopes RD, Moryusef A...> ;The lancet. Diabetes & endocrinology. 2019-07-01
• 1671 citations
  Alirocumab and cardiovascular outcomes after acute coronary syndrome
  Odyssey Outcomes Committees and Investigators, Kinzfogl, G. P.> ;The New England Journal of Medicine. 2018 Nov 7
• Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients.
  Ridker PM, Revkin J, Amarenco P, Brunell R, Curto M, Civeira F, Flather M, Glynn RJ, Gregoire J, Jukema JW, Karpov Y, Kastelein JJP, Koenig W, Lorenzatti A, Manga P, M...> ;The New England journal of medicine. 2017-03-17
• Efficacy and safety of alirocumab in reducing lipids and cardiovascular events.
  Robinson JG, Farnier M, Krempf M, Bergeron J, Luc G, Averna M, Stroes ES, Langslet G, Raal FJ, El Shahawy M, Koren MJ, Lepor NE, Lorenzato C, Pordy R, Chaudhari U, Kas...> ;The New England journal of medicine. 2015-03-15
• Join now to see all

Journal Articles

• Endocarditis in a Community Teaching Hospital: The Framingham Experience.  
  Yang, Ji Hyun MD; Tavares, Liliana MD; Moon, Soo Jin MD; Yoo, Tae Kyung MD; Wagner, Leonardo MD; Barbosa, Felipe MD; Kinzfogl, George MD; Chen, Lucas MD; Treadwell, Th..., Infectious Diseases in Clinical Practice 32(2):e1342, March 2024., 3/2024

Books/Book Chapters

• The 5-Minute Clinical Consult 2012 
  Chapter: Mitral Valve Prolapse 
  Page 838 - 839Deeprasertkul P, Wooding F, Kinzfogl GEditors: Domino, Frank J.Lippincott William & Wilkins, Philadelphia, PA2012
• Diabetes and Cardiovascular Disease 
  Chapter: Diabetes Mellitus and Heart Disease 
  Page 579 - 628Johnstone M, Kinzfogl GEditors: Johnstone M, Veves A.Humana Press, Totowa, NJEdition 2,2005